-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma
-
2024-517284-23-00
5
2025-04-23
Active Psoriatic Arthritis
-
2024-515989-14-00
4
2025-04-17
Nevoid Basal Cell Carcinoma Syndrome
-
2024-511495-32-00
5
2025-04-16
Chronic Phase Chronic Myeloid Leukemia
-
2024-513053-69-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2024-516791-15-00
4
2025-04-08
Relapsed/Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
-
2023-504180-16-00
5
2025-04-07
Advanced Breast Cancer
-
2024-513550-30-00
5
2025-03-28
Newly diagnosed Glioblastoma
-
2024-515214-41-00
5
2025-03-27
advanced pancreatic cancer
-
2024-513862-20-00
5
2025-03-26
Chronic Rhinosinusitis with Nasal Polyposis
-
2024-514643-28-00
4
2025-03-25
Arrhythmogenic Cardiomyopathy (ACM)
-
2024-515861-33-00
4
2025-03-25
Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, an
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2023-505311-20-01
5
2025-03-21
Metastatic Non-Small Cell Lung Cancer
-
2024-513285-19-00
1
2025-03-14
Pancreatic Ductal Adeno Carcinoma
-
2024-515252-20-00
9
2025-03-14
Myelofibrosis (MF) unresponsive to JAK inhibitors
-
2024-511994-31-00
4
2025-03-10
Short Bowel Syndrome and Intestinal Failure (SBS-IF) without colon-in-
-
2024-517262-41-00
5
2025-02-28
Juvenile Psoriatic Arthritis (JPsA)
-
2022-500747-21-00
4
2025-02-27
Geographic Atrophy
-
2023-510292-65-00
5
2025-02-25
chronic graft-versus-host disease
-
2024-514333-37-00
4
2025-02-25
Advanced Metastatic Ocular/Uveal Melanoma
-
2023-509853-29-00
10
2025-02-24
amyotrophic lateral sclerosis
-
2023-509632-26-00
9
2025-02-11
Recurrent or Metastatic Solid Tumors (endometrial cancer (EC); head an
-
2022-502352-31-00
5
2025-02-10
Colorectal Cancer (CRC)